Gene · 338413
Papers2,372
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 2,372
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Possible Modulator of Vitiligo Metabolic Impairment: Rethinking a PPARγ Agonist. | Cells | 2022 | 36429011 | PubTator, text mining | PubMed |
| TNBC Therapeutics Based on Combination of Fusarochromanone with EGFR Inhibitors. | Biomedicines | 2022 | 36428475 | PubTator, text mining | PubMed |
| Extracellular vesicle: A magic lamp to treat skin aging, refractory wound, and pigmented dermatosis? | Front Bioeng Biotechnol | 2022 | 36420445 | PubTator, text mining | PubMed |
| An mTORC1 to HRI signaling axis promotes cytotoxicity of proteasome inhibitors in multiple myeloma. | Cell Death Dis | 2022 | 36400754 | PubTator, text mining | PubMed |
| Translation suppression underlies the restrained COVID-19 mRNA vaccine response in the high-risk immunocompromised group. | Front Immunol | 2022 | 36389788 | PubTator, text mining | PubMed |
| Metformin: Activation of 5' AMP-activated protein kinase and its emerging potential beyond anti-hyperglycemic action. | Front Genet | 2022 | 36386794 | PubTator, text mining | PubMed |
| Colon tumour cell death causes mTOR dependence by paracrine P2X4 stimulation. | Nature | 2022 | 36385525 | PubTator, text mining | PubMed |
| Bone marrow-targetable Green Tea Catechin-Based Micellar Nanocomplex for synergistic therapy of Acute myeloid leukemia. | J Nanobiotechnology | 2022 | 36384529 | PubTator, text mining | PubMed |
| Na+/H+-exchanger 1 enhances antitumor activity of engineered NK-92 natural killer cells. | Cancer Res Commun | 2022 | 36380966 | PubTator, text mining | PubMed |
| Glutathione peroxidase 4 inhibition induces ferroptosis and mTOR pathway suppression in thyroid cancer. | Sci Rep | 2022 | 36371529 | PubTator, text mining | PubMed |
| The Prognostic and Therapeutic Potential of DNA Damage Repair Pathway Alterations and Homologous Recombination Deficiency in Lung Cancer. | Cancers (Basel) | 2022 | 36358724 | PubTator, text mining | PubMed |
| WNK3 inhibition elicits antitumor immunity by suppressing PD-L1 expression on tumor cells and activating T-cell function. | Exp Mol Med | 2022 | 36357569 | PubTator, text mining | PubMed |
| Celecoxib impairs primary human myoblast proliferation and differentiation independent of cyclooxygenase 2 inhibition. | Physiol Rep | 2022 | 36325583 | PubTator, text mining | PubMed |
| Distinct CD4+ T cell signature in ANA-positive young adult patients. | Front Immunol | 2022 | 36311777 | PubTator, text mining | PubMed |
| ShapoGraphy: A User-Friendly Web Application for Creating Bespoke and Intuitive Visualisation of Biomedical Data. | Front Bioinform | 2022 | 36304310 | PubTator, text mining | PubMed |
| Hermansky-Pudlak syndrome type 1 causes impaired anti-microbial immunity and inflammation due to dysregulated immunometabolism. | Mucosal Immunol | 2022 | 36302964 | PubTator, text mining | PubMed |
| Molecular Biomarker Expression in Window of Opportunity Studies for Oestrogen Receptor Positive Breast Cancer-A Systematic Review of the Literature. | Cancers (Basel) | 2022 | 36291809 | PubTator, text mining | PubMed |
| Alpinumisoflavone Impairs Mitochondrial Respiration via Oxidative Stress and MAPK/PI3K Regulation in Hepatocellular Carcinoma Cells. | Antioxidants (Basel) | 2022 | 36290652 | PubTator, text mining | PubMed |
| GABAA receptor function is enhanced by Interleukin-10 in human epileptogenic gangliogliomas and its effect is counteracted by Interleukin-1β. | Sci Rep | 2022 | 36289354 | PubTator, text mining | PubMed |
| Computational quantification and characterization of independently evolving cellular subpopulations within tumors is critical to inhibit anti-cancer therapy resistance. | Genome Med | 2022 | 36266692 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/338413/papers?page=17